Michael Demurjian

Chief Executive Officer at Aspargo Laboratories, Inc.

60 year

Health Technology

Consumer Services

Producer Manufacturing

Michael Demurjian active positions

Companies	Position	Start	End
Tyme, Inc. Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015.	Chief Operating Officer	-	-
Aspargo Laboratories, Inc. Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ.	Chief Executive Officer	-	-
	Chairman	-	-

Career history of Michael Demurjian

Former positions of Michael Demurjian

Companies	Position	Start	End
TYME TECHNOLOGIES, INC.	Director/Board Member	2015-03-31	2019-03-14
	Chief Operating Officer	2015-03-31	2019-03-14
	Director of Finance/CFO	2015-03-31	2015-05-14
	Founder	2011-11-21	2019-03-14
Mikronite Technologies Group, Inc. Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ.	Founder	1992-12-31	2006-12-31
	Sales & Marketing	1992-12-31	2006-12-31
Luminant Biosciences LLC	Founder	2011-08-31	-
Luminant Biosciences LLC	Corporate Officer/Principal	2011-08-31	-

Training of Michael Demurjian

New York University

Undergraduate Degree

Statistics

International

United States

Operational

Founder	3
Chief Operating Officer	2
Director/Board Member	1

Sectoral

Health Technology	4
Consumer Services	2
Producer Manufacturing	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Private companies	5
Tyme Technologies, Inc. Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.	Health Technology
Mikronite Technologies Group, Inc. Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ.	Producer Manufacturing
Tyme, Inc. Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015.	Health Technology
Luminant Biosciences LLC
Aspargo Laboratories, Inc. Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ.	Health Technology

See company connections